Long-term outcome of therapy for 59 cats and 11 dogs with cryptococcosis

Australian Veterinary Journal

Volumn 84, Issue 11, 2006, Pages 384-392

  O'Brien, C R ^a,b   Krockenberger, M B ^a   Martin, P ^a   Wigney, D I ^a   Malik, R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b 250 Princes Hwy   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; FELIDAE;

AMPHOTERICIN B; ANTIPROTOZOAL AGENT; FLUCONAZOLE; ITRACONAZOLE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; COMPARATIVE STUDY; CRYPTOSPORIDIOSIS; DOG; DOG DISEASE; DOSE RESPONSE; FEMALE; HOSPITALIZATION; MALE; PROGNOSIS; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; CAT DISEASES; CATS; CRYPTOSPORIDIOSIS; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUCONAZOLE; ITRACONAZOLE; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 34247370685     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2006.00040.x     Document Type: Article

References (49)

1. Appelbaum E, Shtokalko S. Cryptococcus meningitis arrested with amphotericin. Br Ann Intern Med 1957;47:346-351.
2. Palumbo NE, Perri S. Amphotericin B therapy in two cases of feline cryptococcosis. Vet Med Small Anim Clin 1975;70:553-557.
3. Duckworth RH, Taylor DE, Pickering JG. Letter: C neoformans in the cat. Vet Rec 976;98:18.
4. Thrall MA, Rich LJ, Freemeyer FG. Feline cryptococcosis treatment with amphotericin B. Feline Pract 1976;6:15-28.
5. Bennett JE, Dismukes WE, Duma RJ et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979;301:126-131.
6. Legendre AM, Gompf R, Bone D. Treatment of feline cryptococcosis with ketoconazole. J Am Vet Med Assoc 1982;181:1541-1542.
7. Dunbar M, Pyle RL, Boring JG, McCoy CP. Treatment of canine blastomycosis with ketoconazole. J Am Vet Med Assoc 1983;182:156-157.
8. Noxon JO, Monroe WE, Chinn DR. Disseminated histoplasmosis in a cat: successful treatment with ketoconazole. J Am Vet Med Assoc 1982;181:817-820.
9. Marks DL. Treatment of coccidioidomycosis with ketoconazole. Can Pract 1983;10:35-38.
10. Noxon JO, Monroe WE, Chinn DR. Ketoconazole therapy in canine and feline cryptococcosis. J Am Anim Hosp Assoc 1986;22:179-183.
11. Pentlarge VW, Martin RA. Treatment of cryptococcosis in three cats, using ketoconazole. J Am Vet Med Assoc 1986;188:536-538.
12. Perfect JR, Durack DT, Hamilton JD, Gallis HA. Failure of ketoconazole in cryptococcal meningitis. J Am Med Assoc 1982;247:3349-3351.
13. Berthelin CF, Legendre AM, Bailey CS et al. Cryptococcosis of the nervous system in dogs. Part 2: diagnosis, treatment, monitoring, and prognosis. Prog Vet Neurol 1994;5:136-146.
14. Gerds-Grogan S, Dayrell-Hart B. Feline cryptococcosis: a retrospective study. J Am Anim Hosp Assoc 1997;33:118-122.
15. Shaw SE. Successful treatment of 11 cases of feline cryptococcosis. Aust Vet Pract 1988;18:135-139.
16. Mikiciuk MG, Fales WH, Schmidt DA. Successful treatment of feline cryptococcosis with ketaconazole and flucytosine. J Am Anim Hosp Assoc 1990:26:199-201.
17. Grant SM, Clissold SP. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 1990;39:877-916.
18. Bailey EM, Krakovsky DJ, Rybak MJ. The triazole antifungal agents: a review of itraconazole and fluconazole. Pharmacotherapy 1990;10:146-153.
19. Cleary JD, Taylor JW, Chapman SW. Imidazoles and triazoles in antifungal therapy. Ann Pharmacother 1990;24:148-152.
20. Tucker RM, Williams PL, Arathoon EG et al. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob Agents Chemother 1988;32:369-373.
21. Malik R, Wigney DI, Muir DB et al. Cryptococcosis in cats: clinical and mycological assessment of 29 cases and evaluation of treatment using orally administered fluconazole. J Med Vet Mycol 1992;30:133-144.
22. Denning DW, Tucker RM, Hanson LH et al. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 1989;149:2301-2308.
23. Medleau L, Jacobs GJ, Marks MA. Itraconazole for the treatment of cryptococcosis in cats. J Vet Intern Med 1995;9:39-42.
24. Perfect JR, Savani DV, Durack DT. Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and Candida pyelonephritis in rabbits. Antimicrob Agents Chemother 1986;29:579-583.
25. Malik R, Craig AJ, Wigney DI et al. Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B. Aust Vet J 1996;73:124-128.
26. Saag MS, Graybill RJ, Larsen RA et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000;30:710-718.
27. Singh N. Treatment of opportunistic mycoses: how long is long enough? Lancet Inf Dis 2003;3:703-708.
28. Malik R, Jacobs GJ, Love DN. Cryptococcosis: new perspectives on etiology, pathogenesis, diagnosis, and clinical management. In: August JR, editor. Consultations in Feline Medicine. 4th edn. Saunders, Philadelphia; 2001:39-50.
29. Casadevall A, Perfect JR. Therapy of Cryptococcosis. In: Casadevall A, Perfect JR, editors. Cryptococcus neoformans. ASM Press, Washington, DC; 1998. 457-518.
30. Malik R, Dill-Macky E, Martin P et al. Cryptococcosis in dogs: a retrospective study of 20 consecutive cases. J Med Vet Mycol 1995;33:291-297.
31. O'Brien CR, Krockenberger MB, Wigney DI et al. A retrospecitve study of feline and canine cryptococcosis in Australia from 1981 to 2001:195 cases. Med Mycol 2004;42:449-460.
32. Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 1982;15:535-537.
33. Krockenberger MB, Canfield PJ, Kozel TR et al. An immunohistochemical method that differentiates Cryptococcus neoformans varieties and serotypes in formalin-fixed paraffin-embedded tissues. Med Mycol 2001;39:523-533.
34. Gray LD, Roberts GD. Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen. J Clin Microbiol 1988;26:2450-2451.
35. Stockman L, Roberts GD. Specificity of the latex test for cryptococcal antigen: a rapid, simple method for eliminating interference factors. J Clin Microbiol 1983;17:945-947.
36. Jacobs GJ, Medleau L, Calvert C, Brown J. Cryptococcal infection in cats: factors influencing treatment outcome, and results of sequential serum antigen titers in 35 cats. J Vet Intern Med 1997;11:1-4.
37. Pappas PG, Perfect JR, Cloud GA et al. Cryptococcosis in Human Immunodeficieny Virus-negative patients in the era of effective azole therapy. HIV/AIDS 2001;33:690-699.
38. Kipar A, Kohler K, Leukert W, Reinacher M. A comparison of lymphatic tissues from cats with spontaneous feline infectious peritonitis (FIP), cats with FIP virus infection but no FIP, and cats with no infection. J Comp Pathol 2001;125:182-191.
39. Davies C, Troy GC. Deep mycotic infections in cats. J Am Anim Hosp Assoc 1996;32:380-391.
40. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995;21:28-36.
41. Mitchell DH, Sorrell TC, Allworth AM et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995;20:611-616.
42. Lamothe J. Activity of amphotericin B in lipid emulsion in the initial treatment of canine leishmaniasis. J Small Anim Pract 2001;42:170-175.
43. Malik R, Medeiros C, Wigney DI, Love DN. Suspected drug eruption in seven dogs during administration of flucytosine. Aust Vet J 1996;74:285-288.
44. Papich MG. Table of common drugs: approximate dosages. In: Bonagura JD, editor. Kirk's Current Veterinary Therapy XII, Small Animal Practice. Saunders, Philadelphia; 2000. 1241-1264.
45. Malik R, Speed BR, Kaldor J et al. Serum antibody response to Cryptococcus neoformans in cats, dogs and koalas with and without active infection. Med Mycol 1999;37:43-51.
46. Pfaller MA, Zhang J, Messer SA et al. In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother 1999;43:169-171.
47. Pfaller MA, Messer SA, Hollis RJ, Jones RN. In vitro activities of posaconazole compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans. Antimicrob Agents Chemother 2001;45:2862-2864.
48. Pappas PG, Bustamante B, Ticano E. Adjunctive interferon gamma (IFN-g) for treatment of cryptococcoal meningitis (crypto): a randomised, double-blind pilot trial. In: Proceedings of the 41st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, December 2001.
49. Medleau L. Feline cryptococcosis. In: Kirk R, editor. Current Veterinary Therapy X, Small Animal Practice. Saunders, Philadelphia; 1989:1109-1112.